Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy

British Journal of Haematology

Volumn 169, Issue 4, 2015, Pages 574-583

  Nickel, Robert S ^a,b   Osunkwo, Ifeyinwa ^c   Garrett, Aneesah ^d   Robertson, Jennifer ^d   Archer, David R ^a   Promislow, Daniel E L ^e   Horan, John T ^a   Hendrickson, Jeanne E ^f   Kean, Leslie S ^a,e,g,h  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^h USA   (United States)

Author keywords

Chronic transfusion; Hydroxycarbamide; Immune phenotype; Immunophenotype; Sickle cell disease

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HEMOGLOBIN S; HYDROXYUREA; KI 67 ANTIGEN; ANTISICKLING AGENT;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CHILD; CHRONIC TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL PARAMETERS; IMMUNOPHENOTYPING; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MEMORY T LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL COUNT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SICKLE CELL ANEMIA; T LYMPHOCYTE; TREATMENT OUTCOME; AFRICAN AMERICAN; ANEMIA, SICKLE CELL; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; FOLLOW UP; IMMUNOLOGY; MULTICENTER STUDY;

ADOLESCENT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CHILD; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; LEUKOCYTE COUNT; LEUKOCYTES;

EID: 84928425097     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13326     Document Type: Article

References (49)

1. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. The New England Journal of Medicine, 339, 5-11.
2. Akbar, A.N., Fitzgerald-Bocarsly, P.A., de Sousa, M., Giardina, P.J., Hilgartner, M.W. & Grady, R.W. (1986) Decreased natural killer activity in thalassemia major: a possible consequence of iron overload. The Journal of Immunology, 136, 1635-1640.
3. Balkaran, B., Char, G., Morris, J., Thomas, P., Serjeant, B. & Serjeant, G. (1992) Stroke in a cohort of patients with homozygous sickle cell disease. Journal of Pediatrics, 120, 360-366.
4. Barrett-Connor, E. (1971) Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore), 50, 97-112.
5. Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P. & Vercellotti, G.M. (2000) Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood, 96, 2451-2459.
6. Bolanos-Meade, J., Fuchs, E.J., Luznik, L., Lanzkron, S., Gamper, C., Jones, R.J. & Brodsky, R. (2012) HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood, 120, 4285-4291.
7. Brousse, V., Gandhi, S., de Montalembert, M., Height, S., Dick, M.C., O'Driscoll, S., Abihsera, G. & Rees, D.C. (2013) Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia. British Journal of Haematology, 160, 259-261.
8. Castellino, S.M., Combs, M.R., Zimmerman, S.A., Issitt, P.D. & Ware, R.E. (1999) Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. British Journal of Haematology, 104, 189-194.
9. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J. & Levy, P. (1994) The acute chest syndrome in sickle cell disease incidence and risk factors. Blood, 84, 643-649.
10. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. The New England Journal of Medicine, 332, 1317-1322.
11. Chou, S.T., Jackson, T., Vege, S., Smith-Whitley, K., Friedman, D.F. & Westhoff, C.M. (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 122, 1062-1071.
12. Culhane, A.C., Thioulouse, J., Perriere, G. & Higgins, D.G. (2005) MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics, 21, 2789-2790.
13. Cunningham-Rundles, S., Giardina, P.J., Grady, R.W., Califano, C., McKenzie, P. & De Sousa, M. (2000) Effect of transfusional iron overload on immune response. Journal of Infectious Diseases, 182, S115-S121.
14. Dedeken, L., Le, P.Q., Azzi, N., Brachet, C., Heijmans, C., Huybrechts, S., Devalck, C., Rozen, L., Ngalula, M. & Ferster, A. (2014) Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. British Journal of Haematology, 165, 402-408.
15. Duits, A.J., Schnog, J.B., Lard, L.R., Saleh, A.W. & Rojer, R.A. (1998) Elevated IL-8 levels during sickle cell crisis. European Journal of Haematology, 61, 302-305.
16. Fadlon, E., Vordermeier, S., Pearson, T.C., Mire-Sluis, A.R., Dumonde, D.C., Phillips, J., Fishlock, K. & Brown, K.A. (1998) Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood, 91, 266-274.
17. Field, J.J., Lin, G., Okam, M.M., Majerus, E., Keefer, J., Onyekwere, O., Ross, A., Campigotto, F., Neuberg, D., Linden, J. & Nathan, D.G. (2013) Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood, 121, 3329-3334.
18. Grady, R.W., Akbar, A.N., Giardina, P.J., Hilgartner, M.W. & de Sousa, M. (1985) Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy. British Journal of Haematology, 59, 713-724.
19. Haywood, Jr, C., Beach, M.C., Bediako, S., Carroll, C.P., Lattimer, L., Jarrett, D. & Lanzkron, S. (2011) Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. American Journal of Hematology, 86, 85-87.
20. Holtzclaw, J.D., Jack, D., Aguayo, S.M., Eckman, J.R., Roman, J. & Hsu, L.L. (2004) Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. American Journal of Respiratory and Critical Care Medicine, 169, 687-695.
21. Horan, J.T., Liesveld, J.L., Fenton, P., Blumberg, N. & Walters, M.C. (2005) Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplantation, 35, 171-177.
22. Iannone, R., Casella, J.F., Fuchs, E.J., Chen, A.R., Jones, R.J., Woolfrey, A., Amylon, M., Sullivan, K.M., Storb, R.F. & Walters, M.C. (2003) Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia. Biology of Blood and Marrow Transplantation, 9, 519-528.
23. Jacobsohn, D.A., Duerst, R., Tse, W. & Kletzel, M. (2004) Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. The Lancet, 364, 156-162.
24. Kamani, N.R., Walters, M.C., Carter, S., Aquino, V., Brochstein, J.A., Chaudhury, S., Eapen, M., Freed, B.M., Grimley, M., Levine, J.E., Logan, B., Moore, T., Panepinto, J., Parikh, S., Pulsipher, M.A., Sande, J., Schultz, K.R., Spellman, S. & Shenoy, S. (2012) Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation, 18, 1265-1272.
25. Kaplan, J., Sarnaik, S., Gitlin, J. & Lusher, J. (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood, 64, 308-310.
26. Kharbanda, S., Smith, A.R., Hutchinson, S.K., McKenna, D.H., Ball, J.B., Lamb, Jr, L.S., Agarwal, R., Weinberg, K.I. & Wagner, Jr, J.E. (2014) Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells. Biology of Blood and Marrow Transplantation, 20, 581-586.
27. Kinney, T., Sleeper, L., Wang, W.C., Zimmerman, R., Pegelow, C., Ohene-Frempong, K., Wethers, D., Bello, J., Vichinsky, E., Moser, F., Gallagher, D., DeBaun, M., Platt, O. & Miller, S.T. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics, 103, 640-645.
28. Lard, L.R., Mul, F.P., de Haas, M., Roos, D. & Duits, A.J. (1999) Neutrophil activation in sickle cell disease. Journal of Leukocyte Biology, 66, 411-415.
29. Lebensburger, J.D., Sidonio, R.F., Debaun, M.R., Safford, M.M., Howard, T.H. & Scarinci, I.C. (2013) Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea. Pediatric Blood & Cancer, 60, 1333-1337.
30. Lederman, H.M., Connolly, M.A., Kalpatthi, R., Ware, R.E., Wang, W.C., Luchtman-Jones, L., Waclawiw, M., Goldsmith, J.C., Swift, A. & Casella, J.F. (2014) Immunologic effects of hydroxyurea in sickle cell anemia. Pediatrics, 134, 686-695.
31. Oyeku, S.O., Driscoll, M.C., Cohen, H.W., Trachtman, R., Pashankar, F., Mullen, C., Giardina, P.J., Velazco, N., Racine, A.D. & Green, N.S. (2013) Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease. Pediatric Blood & Cancer, 60, 653-658.
32. Pahwa, S., Sia, C., Harper, R. & Pahwa, R. (1985) T lymphocyte subpopulations in high-risk infants: influence of age and blood transfusions. Pediatrics, 76, 914-917.
33. Pathare, A., Al Kindi, S., Alnaqdy, A.A., Daar, S., Knox-Macaulay, H. & Dennison, D. (2004) Cytokine profile of sickle cell disease in Oman. American Journal of Hematology, 77, 323-328.
34. Platt, O. (2000) Sickle cell anemia as an inflammatory disease. The Journal of Clinical Investigation, 106, 337-338.
35. Platt, O., Brambilla, D., Rosse, W., Milner, P., Castro, O., Steinberg, M. & Klug, P. (1994) Mortality in sickle cell disease life expectancy and risk factors for early death. The New England Journal of Medicine, 1994, 1939-1944.
36. Polanowska-Grabowska, R., Wallace, K., Field, J.J., Chen, L., Marshall, M.A., Figler, R., Gear, A.R. & Linden, J. (2010) P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2392-2399.
37. Purohit, S., Alvarez, O., O'Brien, R. & Andreansky, S. (2012) Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions. Pediatric Blood & Cancer, 59, 1280-1283.
38. Quinn, C., Lee, N., Shull, E., Ahmad, N., Rogers, Z.R. & Buchanan, G.R. (2008) Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. Blood, 111, 544-548.
39. Sainani, K.L. (2014) Introduction to principal components analysis. PM & R: the Journal of Injury, Function, and Rehabilitation, 6, 275-278.
40. Thornburg, C.D., Files, B.A., Luo, Z., Miller, S.T., Kalpatthi, R., Iyer, R., Seaman, P., Lebensburger, J., Alvarez, O., Thompson, B., Ware, R.E. & Wang, W.C.; BABY HUG Investigators. (2012) Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood, 120, 4304-4310; quiz 4448.
41. Vamvakas, E.C. & Blajchman, M.A. (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Reviews, 21, 327-348.
42. Vingert, B., Tamagne, M., Desmarets, M., Pakdaman, S., Elayeb, R., Habibi, A., Bernaudin, F., Galacteros, F., Bierling, P., Noizat-Pirenne, F. & Cohen, J. (2014) Partial dysfunction of Treg activation in sickle cell disease. American Journal of Hematology, 89, 261-266.
43. Walker, Jr, E.M. & Walker, S.M. (2000) Effects of iron overload on the immune system. Annals of Clinical & Laboratory Science, 30, 354-365.
44. Wallace, K.L., Marshall, M.A., Ramos, S.I., Lannigan, J.A., Field, J.J., Strieter, R.M. & Linden, J. (2009) NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood, 114, 667-676.
45. Wang, W.C. & Dwan, K. (2013) Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. The Cochrane Database Systematic Reviews, 11, CD003146.
46. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X. & Thompson, B.W. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). The Lancet, 377, 1663-1672.
47. West, M., Wethers, D., Smith, J. & Steinberg, M. (1992) Laboratory profile of sickle cell disease: a cross-sectional analysis. Journal of Clinical Epidemiology, 45, 893-909.
48. Wong, W.Y., Powars, D.R., Operskalski, E.A., Hassett, J., Parker, J.W., Sarnaik, S., Pegelow, C.H., Hilgartner, M.W., Johnson, C.S. & Zhou, Y. (1995) Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group. Blood, 85, 2091-2097.
49. Wun, T., Cordoba, M., Rangaswami, A., Cheung, A.W. & Paglieroni, T. (2002) Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clinical and Laboratory Haematology, 24, 81-88.